MariMed Inc.
MRMD
$0.07
$0.000.14%
OTC PK
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -5.21% | 2.17% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -5.21% | 2.17% | |||
| Cost of Revenue | -22.29% | 27.65% | |||
| Gross Profit | 45.46% | -35.82% | |||
| SG&A Expenses | 0.30% | 2.18% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -14.97% | 18.11% | |||
| Operating Income | 106.63% | -354.30% | |||
| Income Before Tax | 84.77% | -3,926.37% | |||
| Income Tax Expenses | 198.66% | -197.39% | |||
| Earnings from Continuing Operations | 18.83% | -57.80% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -280.00% | 242.86% | |||
| Net Income | 18.27% | -57.09% | |||
| EBIT | 106.63% | -354.30% | |||
| EBITDA | 338.12% | -134.26% | |||
| EPS Basic | 18.80% | -56.00% | |||
| Normalized Basic EPS | 75.24% | -10,400.00% | |||
| EPS Diluted | 14.53% | -17.00% | |||
| Normalized Diluted EPS | 75.24% | -10,400.00% | |||
| Average Basic Shares Outstanding | 0.54% | 0.68% | |||
| Average Diluted Shares Outstanding | 0.54% | 0.68% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||